Book cover for Pharmacology and the Nursing Process

Pharmacology and the Nursing Process

Linda Lane Lilley, Shelly Rainforth Collins, Julie S. Snyder

ISBN #9780323087896

7th Edition

394 Questions

Group icon
2,697 Students Helped

Homework Questions

Right arrow
Summary
Learning Objectives
Key Concepts
Example Problems
Explanations
Common Mistakes

Summary

This chapter provides an extensive review of several key drug classes, including alpha blockers, beta blockers, and alkylating agents, emphasizing their clinical indications, pharmacokinetic properties, contraindications, and potential drug interactions. The ability to tailor therapy based on individual patient factors and understanding the mechanism of these drugs is essential for safe and effective treatment outcomes. Understanding these profiles helps ensure that patients receive the most appropriate therapy for managing hypertension, cardiac conditions, BPH, and cancer.

Learning Objectives

1

Describe the mechanism of action, pharmacokinetic profiles, and clinical applications of alpha blockers, beta blockers, and alkylating agents.

2

Identify the indications, contraindications, and potential drug interactions associated with these drug classes.

3

Analyze the importance of selecting the appropriate drug based on patient-specific factors in the management of hypertension, BPH, cardiac conditions, and chemotherapy regimens.

4

Evaluate the role of pharmacokinetics in ensuring the safe and effective use of these agents in various clinical scenarios.

Key Concepts

CONCEPT

DEFINITION

Alpha Blockers

Drugs such as phentolamine and tamsulosin that act by blocking alpha-adrenergic receptors to lower blood pressure and relieve urinary symptoms associated with BPH.

Beta Blockers

Medications that reduce myocardial oxygen demand by blocking beta-adrenergic receptors, with cardioselective options being particularly useful in patients with cardiac conditions.

Alkylating Agents

Chemotherapeutic drugs like cisplatin that interfere with DNA replication by forming covalent bonds with DNA, leading to cell death.

Pharmacokinetics

The study of how a drug is absorbed, distributed, metabolized, and excreted in the body, which is crucial in determining appropriate dosing regimens and minimizing adverse effects.

Contraindications

Specific situations or conditions in which a drug should not be used because it may be harmful to the patient.

Drug Interactions

Unexpected or adverse effects that occur when two or more drugs are administered together, potentially altering the efficacy or safety of one or more of the drugs.

Example Problems

Example 1

A nurse administering niacin would implement which action to help to reduce adverse effects? a Give the medication with grapefruit juice. b Administer a small dose of aspirin or an NSAID 30 minutes before the niacin dose. c Administer the medication on an empty stomach. d Have the patient increase dietary fiber intake.

Example 2

When administering niacin, the nurse needs to monitor for which adverse effect? a Cutaneous flushing b Muscle pain c Headache d Constipation

Example 3

Which point will the nurse emphasize to a patient who is taking an antilipemic medication in the "statin" class? a The drug needs to be taken on an empty stomach before meals. b A low-fat diet is not necessary while taking these medications. $c$ It is important to report muscle pain immediately. d Improved cholesterol levels will be evident within 2 weeks.

Example 4

A patient is being assessed before a newly ordered antilipe mic medication is given. Which condition would be a poten tial contraindication? a Diabetes insipidus b Pulmonary fibrosis c Liver cirrhosis d Myocardial infarction

Example 5

A patient is currently taking a statin. The nurse considers that the patient may have a higher risk of developing rhabdomyolysis when also taking which product? a NSAIDs b A fibric acid derivative c Orange juice d Fat soluble vitamins
Scroll left
Scroll right

Step-by-Step Explanations

QUESTION

How would you determine if an alpha blocker is appropriate for a patient with both hypertension and BPH?

STEP-BY-STEP ANSWER:

Step 1: Review the patient's medical history including blood pressure levels and symptoms related to BPH.
Step 2: Evaluate the drug profiles of alpha blockers such as phentolamine and tamsulosin to understand their receptor selectivity and clinical benefits.
Step 3: Consider pharmacokinetic properties that could affect dosing, such as absorption rate, half-life, and metabolism.
Step 4: Assess potential contraindications (e.g., severe hypotension) and the risk of drug interactions with the patient’s current medications.
Step 5: Select the drug that offers the optimal balance between managing hypertension and alleviating BPH symptoms, while minimizing risks.
Final Answer: An appropriate alpha blocker, with careful consideration of pharmacokinetics and contraindications, is chosen based on individualized patient factors.

Selecting an Alpha Blocker for a Patient with Hypertension and BPH

QUESTION

What steps should be taken when prescribing a cardioselective beta blocker for cardiac protection?

STEP-BY-STEP ANSWER:

Step 1: Determine the indication for beta blocker therapy, such as reducing myocardial oxygen demand in patients with angina or after myocardial infarction.
Step 2: Identify the cardioselective beta blockers because they primarily target beta-1 receptors, reducing cardiac workload with fewer pulmonary side effects.
Step 3: Review the patient’s current medications and medical history for any contraindications or potential interactions.
Step 4: Monitor the patient’s heart rate and blood pressure after initiation of therapy to ensure efficacy and safety.
Step 5: Adjust the dosage as needed based on therapeutic response and any observed side effects.
Final Answer: The safe and effective use of cardioselective beta blockers involves patient-specific evaluation, careful monitoring, and appropriate dosage adjustments.

Using Cardioselective Beta Blockers in Cardiac Protection

QUESTION

What steps are important when considering the use of an alkylating agent like cisplatin in a chemotherapy regimen?

STEP-BY-STEP ANSWER:

Step 1: Confirm the cancer diagnosis and assess the specific type of tumor to determine if an alkylating agent is appropriate.
Step 2: Review the pharmacokinetic profile of cisplatin, including its mechanism of action in interfering with DNA replication.
Step 3: Evaluate the patient’s overall health, kidney function, and potential risk factors for cisplatin-induced toxicity.
Step 4: Consider drug interactions with other components of the chemotherapy regimen that might enhance toxicity or reduce efficacy.
Step 5: Initiate treatment with careful monitoring of kidney function, blood counts, and other relevant parameters.
Final Answer: The use of cisplatin in chemotherapy is implemented through thorough patient evaluation, understanding of pharmacokinetics and mechanism of action, and vigilant monitoring for toxicity.

Implementing Alkylating Agents in Chemotherapy

Scroll left
Scroll right

Common Mistakes

  • Assuming that all beta blockers have the same level of selectivity and therefore can be used interchangeably without considering individual patient respiratory issues.
  • Overlooking the importance of pharmacokinetic profiles which can lead to improper dosing and increased risk of adverse effects.
  • Failing to recognize specific contraindications or potential drug interactions, which can compromise patient safety.
  • Mixing up the indications of alpha blockers and alkylating agents, resulting in inappropriate therapy selection for conditions like hypertension versus cancer.